Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sequenom SQNM

Healthcare Biotechnology
"Sequenom Inc is a molecular diagnostic testing and genetics analysis company which provides molecular diagnostic testing services."

Recent & Breaking News (NDAQ:SQNM)

Sequenom Laboratories Launches The HerediT® UNIVERSAL Test In Collaboration With Recombine

PR Newswire March 19, 2015

Kenneth Buechler Elected Chairman of Sequenom Board of Directors

PR Newswire March 17, 2015

Sequenom Reports 2014 Final And Fourth Quarter Financials

PR Newswire March 4, 2015

Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2014 Financial Results And Conference Call

PR Newswire February 19, 2015

Cypher Genomics and Sequenom Announce Development Agreement

PR Newswire January 22, 2015

Sequenom, Inc. Announces Participation At The 33rd Annual J.P. Morgan Healthcare Conference

PR Newswire January 6, 2015

Illumina and Sequenom Pool Noninvasive Prenatal Testing Intellectual Property and End Outstanding Patent Disputes

Business Wire December 3, 2014

Sequenom, Inc. Announces Participation At The 26th Annual Piper Jaffray Healthcare Conference

PR Newswire November 25, 2014

Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2014

PR Newswire November 4, 2014

Sequenom, Inc. Announces Date Of Third Quarter 2014 Financial Results And Conference Call

PR Newswire October 21, 2014

Sequenom Purchases Noninvasive Prenatal Testing Intellectual Property From Isis Innovation

PR Newswire October 6, 2014

Sequenom Laboratories Presents New Data Supporting The Accuracy Of The MaterniT21® Plus Laboratory Developed Test In Clinical Setting

PR Newswire September 22, 2014

Sequenom, Inc. Announces Participation At The 2014 Morgan Stanley Global Healthcare Conference

PR Newswire September 2, 2014

Sequenom, Inc. Announces Participation At The 2014 Wedbush Securities Life Sciences Management Access Conference

PR Newswire August 5, 2014

Sequenom Enters Into License Agreement With Mayo Medical Laboratories

PR Newswire July 29, 2014

Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014

PR Newswire July 29, 2014

Sequenom Laboratories Presents New Data on the Enhanced Sequencing Series for the MaterniT21(TM) Plus Laboratory-Developed Test At 18th International Conference on Prenatal Diagnosis and Therapy

PR Newswire July 22, 2014

Sequenom Laboratories Expands International Noninvasive Prenatal Testing Services To Broader Population With VisibiliT(TM) Test

PR Newswire July 21, 2014

Sequenom, Inc. Announces Date Of Second Quarter 2014 Financial Results And Conference Call

PR Newswire July 15, 2014

Sequenom Laboratories and Quest Diagnostics Collaborate to Expand Patient Access to the MaterniT21(TM) PLUS Noninvasive Prenatal Test

PR Newswire June 16, 2014